ML21053A025

NRR E-mail Capture - Request for Additional Information (Rais) - LaSalle Request for Exemption from Pre-Access Drug and Alcohol Testing

ML21053A025
Person / Time
Site:	Beaver Valley, LaSalle
Issue date:	02/20/2021
From:	Bhalchandra Vaidya NRC/NRR/DORL/LPL3
To:	Kusumawatimurray P, Taken J Exelon Generation Co
References
L-2020-LLE-0011
Download: ML21053A025 (3)

Text

From: Vaidya, Bhalchandra Sent: Saturday, February 20, 2021 7:02 PM To: Taken, Jason C.:(Exelon Nuclear); Kusumawatimurray, Putri:(GenCo-Nuc)

Cc: Harris, Paul; Zaleski, Brian; Bowers, Anthony; Salgado, Nancy; Danna, James; Marshall, Michael; Poole, Justin; Purnell, Blake; Wall, Scott

Subject:

Request for Additional Information (RAIs) - LaSalle Request for Exemption from Pre-Access Drug and Alcohol Testing

Subject:

Request for Additional Information (RAIs) for LaSalle Request for Exemption from Pre-Access Drug and Alcohol Testing requirements in 10 CFR 26.65 By letter dated February 20, 2021 (ADAMS Accession No. ML21051A006), Exelon Generation Company, LLC (EGC) requested Exemption from Pre-Access Drug and Alcohol Testing requirements in 10 CFR 26.65.

The U.S. Nuclear Regulatory Commission (NRC) staff is reviewing your submittal and has identified areas where additional information is needed to complete its review. Please find the request for additional information (RAI) below.

Based on the Clarification Telephone Discussion with your staff on Saturday, February 20, 2021, You indicated that the Responses to the RAIs will be submitted by supplemental submission as early as possible on February 21, 2021.

Please contact me, if you have any questions.

Thanks.

=

Request for Additional Information (RAIs) for LaSalle Request for Exemption from Pre-Access Drug and Alcohol Testing requirements in 10 CFR 26.65 Please provide Responses to the following questions:

Administrative RAI-1. What is Exelons justification for the 10 additional business days (14 calendar days) for each event?

RAI-2. Explain whether Exelon explored alternative shipping options and the use of a back-up U.S.

Department of Health and Human Services (HHS)-certified laboratory?

RAI-3. Explain whether there is a drop dead date from the point of specimen collection from which Exelon will cancel the initial test and retest individuals prior to their requested 10-day extension to help ensure these individuals are fit for duty and trustworthy and reliable?

RAI-4. What are Exelon plans if an individual has completed assigned work activities and is no longer onsite, but the individuals test result comes back and its positive or invalid?

Quantifying Risk RAI-5. What is Exelons qualitative assessment of the size of the group of affected individuals that are reinstates less than 30 days and those who are greater than 30 days but less than 365 days? Contrast this assessment to the size of the outage worker population.

RAI-6. What is Exelons qualitative assessment of the number of affected individuals in follow-up testing?

Mitigating Risk RAI-7. Does Exelon plan to implement any mitigative strategies above that required by the regulations to ensure that the affective population is fit for duty and trustworthy and reliable during the interim period?

==

Bhalchandra K. Vaidya US Nuclear Regulatory Commission Office of Nuclear Reactor Regulation Division of Operatig Reactor Licensing LPL3 301-415-3308 Bhalchandra.vaidya@nrc.gov

Hearing Identifier: NRR_DRMA Email Number: 1034 Mail Envelope Properties (SJ0PR09MB72161C7C57F2B2416BF7EB958D829)

Subject:

Request for Additional Information (RAIs) - LaSalle Request for Exemption from Pre-Access Drug and Alcohol Testing Sent Date: 2/20/2021 7:01:45 PM Received Date: 2/20/2021 7:01:45 PM From: Vaidya, Bhalchandra Created By: Bhalchandra.Vaidya@nrc.gov Recipients:

"Harris, Paul" <Paul.Harris@nrc.gov>

Tracking Status: None "Zaleski, Brian" <Brian.Zaleski@nrc.gov>

Tracking Status: None "Bowers, Anthony" <Anthony.Bowers@nrc.gov>

Tracking Status: None "Salgado, Nancy" <Nancy.Salgado@nrc.gov>

Tracking Status: None "Danna, James" <James.Danna@nrc.gov>

Tracking Status: None "Marshall, Michael" <Michael.Marshall@nrc.gov>

Tracking Status: None "Poole, Justin" <Justin.Poole@nrc.gov>

Tracking Status: None "Purnell, Blake" <Blake.Purnell@nrc.gov>

Tracking Status: None "Wall, Scott" <Scott.Wall@nrc.gov>

Tracking Status: None "Taken, Jason C.:(Exelon Nuclear)" <Jason.Taken@exeloncorp.com>

Tracking Status: None "Kusumawatimurray, Putri:(GenCo-Nuc)" <Putri.Kusumawatimurray@exeloncorp.com>

Tracking Status: None Post Office: SJ0PR09MB7216.namprd09.prod.outlook.com Files Size Date & Time MESSAGE 2895 2/20/2021 7:01:45 PM Options Priority: Normal Return Notification: No Reply Requested: No Sensitivity: Normal Expiration Date: